The Rise of Consumer Diagnostics and Emerging Trends
Consumer diagnostics will be one of several discussions at the INVEST Digital Health conference focused on power shifting to the consumer in healthcare. The conference is scheduled for October 29 in Dallas at Pegasus Park, in partnership with Health Wildcatters.
Healthcare Is Deploying AI Tools — It’s Not Ready for AI Colleagues
Most healthcare organizations are experimenting with AI. Few are preparing to manage AI agents as participants in everyday healthcare workflows.
presented by
How Payers and Health Plans Think of Identity and the Risks of Fragmented Data
A recent webinar, sponsored by Verato, offered insights from executives at SCAN Health Plan and the Alliance of Community Health Plans on a wide range of tech challenges in healthcare from fragmented data to technology architecture to patient identity.
The Reimbursement Challenges Hurting Women’s Health Companies, Per Milken Institute
Women’s health startups should plan for reimbursement early, as limited research and evidence can make securing coverage difficult, a new report explains.
Vogenx IPO Raises $81M for Trial in Metabolic Disease With No Approved Drugs
Vogenx’s mizagliflozin is heading into Phase 2b testing for post-bariatric hypoglycemia (PBH). Amylyx Pharmaceuticals and Recordati are developing injectable peptide drugs for this metabolic disorder, but Vogenx aims to stand apart by offering patients a different mechanism of action and oral dosing.